Veterinary medicines European public assessment report (EPAR): Solensia, frunevetmab, Status: Authorised
Human medicines European public assessment report (EPAR): Stayveer, bosentan monohydrate, Date of authorisation: 24/06/2013, Revision: 18, Status: Authorised
Veterinary medicines European public assessment report (EPAR): ProteqFlu-Te, equine influenza (live recombinant) and tetanus vaccine, Status: Authorised
5 fluorouracil
Veterinary medicines European public assessment report (EPAR): Innovax-ILT, avian infectious laryngotracheitis and Marek’s disease vaccine (live), Status: Authorised
Timetable: Annual reassessment - ATMP
Timetable: Annual renewal application of conditional marketing authorisation - ATMP
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 14-17 October 2024
List of medicines currently in PRIME scheme
Timetable: Marketing authorisation renewal application - ATMP